Status:
UNKNOWN
Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)
Lead Sponsor:
AMAG Pharmaceuticals, Inc.
Conditions:
Peripheral Arterial Disease (PAD)
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to compare the difference between two magnetic resonance imaging (MRI) techniques for visualizing arteries. The study hypothesizes that one method that relies upon imaging...
Eligibility Criteria
Inclusion
- Subjects with symptoms of PAD
- Scheduled for DSA
Exclusion
- Critical leg ischemia manifested by ulcers, gangrene or leg amputation
- Laboratory evidence of iron overload, liver disease, pregnancy
- History of allergy to or recent exposure to radiocontrast, gadolinium chelates, or intravenous iron therapy
- Clinical concerns about co-morbidities, subject suitability
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2019
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT00707876
Start Date
September 1 2008
End Date
August 1 2019
Last Update
April 26 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lexington, Massachusetts, United States, 02421